Matches in Wikidata for { <http://www.wikidata.org/entity/Q84752151> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q84752151 description "artículu científicu espublizáu n'agostu de 2012" @default.
- Q84752151 description "im August 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84752151 description "scientific article published on 01 August 2012" @default.
- Q84752151 description "wetenschappelijk artikel" @default.
- Q84752151 description "наукова стаття, опублікована в серпні 2012" @default.
- Q84752151 name "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 name "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 type Item @default.
- Q84752151 label "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 label "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 prefLabel "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 prefLabel "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 P1433 Q84752151-7933F47F-46AF-418B-8706-7904013C0C15 @default.
- Q84752151 P1476 Q84752151-B8288908-C70A-4ECF-A028-8ED645D08173 @default.
- Q84752151 P2093 Q84752151-2F30F5BF-6020-4FF8-A1F4-178AF6BD1F42 @default.
- Q84752151 P2860 Q84752151-061ED1E3-C6FA-4D6F-B33F-398DF4C944CE @default.
- Q84752151 P2860 Q84752151-4629D614-9CF9-438E-875B-3519CFA5527C @default.
- Q84752151 P2860 Q84752151-693B2B3A-1F36-4923-A83C-DED9F4AF5C39 @default.
- Q84752151 P2860 Q84752151-A12BB569-558C-408C-A44A-874137154670 @default.
- Q84752151 P304 Q84752151-9C92915D-9E16-47AD-B9C0-E7C616C889B5 @default.
- Q84752151 P31 Q84752151-24C5D81A-FC41-454F-813A-A9AA47AEECCF @default.
- Q84752151 P356 Q84752151-70233C8D-8521-43B5-9D49-E09286187D2F @default.
- Q84752151 P478 Q84752151-2694F4F8-9547-43EF-832C-7825C8874C86 @default.
- Q84752151 P577 Q84752151-0CE5C827-A0B5-45C5-84F0-890EAC6DCE34 @default.
- Q84752151 P698 Q84752151-7B053204-61FB-4E7D-B2DD-E67B422E5DBC @default.
- Q84752151 P921 Q84752151-22343537-EB2F-4ED7-8C59-BF64E295311F @default.
- Q84752151 P356 BF03265491 @default.
- Q84752151 P698 22873622 @default.
- Q84752151 P1433 Q15753215 @default.
- Q84752151 P1476 "Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice" @default.
- Q84752151 P2093 "Andrew X Zhu" @default.
- Q84752151 P2860 Q28306363 @default.
- Q84752151 P2860 Q34622672 @default.
- Q84752151 P2860 Q42704646 @default.
- Q84752151 P2860 Q42762728 @default.
- Q84752151 P304 "1-2" @default.
- Q84752151 P31 Q13442814 @default.
- Q84752151 P356 "10.1007/BF03265491" @default.
- Q84752151 P478 "32 Suppl 2" @default.
- Q84752151 P577 "2012-08-01T00:00:00Z" @default.
- Q84752151 P698 "22873622" @default.
- Q84752151 P921 Q1148337 @default.